IDEXX Laboratories Inc (IDXX)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	845,042	822,728	791,435	699,178	679,089	669,653	663,950	734,553	744,845	756,864	727,848	674,206	581,776	497,482	460,100	436,866	427,720	422,862	407,276	390,261
Revenue (ttm)	US$ in thousands	3,660,953	3,587,920	3,514,054	3,430,970	3,367,324	3,339,846	3,308,606	3,274,202	3,215,360	3,135,208	3,046,576	2,858,026	2,706,655	2,591,163	2,474,677	2,457,188	2,406,908	2,350,848	2,290,993	2,251,642
Net profit margin		23.08%	22.93%	22.52%	20.38%	20.17%	20.05%	20.07%	22.43%	23.17%	24.14%	23.89%	23.59%	21.49%	19.20%	18.59%	17.78%	17.77%	17.99%	17.78%	17.33%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $845,042K ÷ $3,660,953K
= 23.08%

The net profit margin of Idexx Laboratories, Inc. has shown stability and consistent profitability over the past eight quarters, ranging from 20.05% to 23.08%. This indicates that the company effectively manages its expenses and generates healthy profits relative to its revenue during this period. The slight fluctuation in the net profit margin may be attributable to various factors such as changes in operating costs, pricing strategies, or revenue growth. Overall, Idexx Laboratories, Inc. has maintained a strong level of profitability as evidenced by its relatively high and steady net profit margins.